Image: The ConversationFDA drug approval affects healthcare around the world, but political shortcuts could hurt the agency’s international reputation
• The FDA has introduced a new fast-track program for the approval of biologics, which are complex drugs used to treat conditions such as cancer and sickle cell disease. • Traditionally, the agency requires a rigorous process involving an investigational new drug application followed by three distinct phases of human clinical trials. • Experts warn that these political shortcuts could undermine the FDA's international reputation and its standing as a global authority on drug safety.
theconversation.com







